Skyrizi 360 MG/2.4 ML on-body 2.4ML
Ended Awarded
- Contract number
- SPE2DR26FV5PN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,467
Award facts
- Contract value 100% obligated
- $12,467.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $12,467 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of SKYRIZI 360 mg/2.4 ml on-body 2.4ml, a prescription biologic medication. The contract was awarded on November 20, 2025, with an ultimate completion date of December 12, 2025, and represents a non-set-aside competitive award. Performance will be conducted at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026, which serves as the primary pharmaceutical supply vehicle for military healthcare systems globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor that supplies an extensive portfolio of brand-name and generic medications, specialty pharmaceuticals, vaccines, and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's substantial IDC with DLA enables flexible procurement of pharmaceutical products across multiple therapeutic domains to support military medical operations worldwide. This delivery order for SKYRIZI demonstrates the company's role in ensuring timely access to specialized biologics necessary for military personnel and beneficiary healthcare needs.
Quick answers
Who was awarded contract SPE2DR26FV5PN?
SPE2DR26FV5PN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 20, 2025.
How much is contract SPE2DR26FV5PN worth?
The government has obligated $12,467 on SPE2DR26FV5PN.
Is contract SPE2DR26FV5PN an order under another contract?
Yes. SPE2DR26FV5PN is a delivery order under SPE2DR25D7055, an indefinite delivery contract.
Was contract SPE2DR26FV5PN competed?
The extent of competition for SPE2DR26FV5PN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award